Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CHRAC1 (1-131) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CHRAC1 |
Gene ID: |
54108 |
Uniprot ID: |
CHRC1_HUMAN |
Immunogen Region: |
1-131 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-131 of human CHRAC1 (NP_059140.1). |
Immunogen Sequence: |
MADVVVGKDKGGEQRLISLP LSRIRVIMKSSPEVSSINQE ALVLTAKATELFVQCLATYS YRHGSGKEKKVLTYSDLANT AQQSETFQFLADILPKKILA SKYLKMLKEEKREEDEENDN DNESDHDEADS |
Tissue Specificity | Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. |
Function | Forms a complex with DNA polymerase epsilon subunit POLE3 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome remodeling activity of ISWI/SNF2H and ACF1. Does not enhance nucleosome sliding activity of the ACF-5 ISWI chromatin remodeling complex. |
Protein Name | Chromatin Accessibility Complex Protein 1Chrac-1Chromatin Accessibility Complex 15 Kda ProteinChrac-15Huchrac15Dna Polymerase Epsilon Subunit P15 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Chromatin Accessibility Complex Protein 1 antibodyAnti-Chrac-1 antibodyAnti-Chromatin Accessibility Complex 15 Kda Protein antibodyAnti-Chrac-15 antibodyAnti-Huchrac15 antibodyAnti-Dna Polymerase Epsilon Subunit P15 antibodyAnti-CHRAC1 antibodyAnti-CHRAC15 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance